Platelet Rich Plasma Therapies
Medicare Advantage policy governing the use, coding, and Medicare-related coverage considerations for autologous platelet-rich plasma therapies for UnitedHealthcare Medicare Advantage plans and affiliated providers.
Updated list of CMS Medicare Coverage Database documents to reflect the most current information.
Previous policy version MMP392.03 archived.
Coverage Determinations and Criteria
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.